Supply of Brand-Name NETSPOT (Gallium Ga-68) Radiopharmaceutical Doses

This contract involves the procurement and delivery of FDA-approved, brand-name NETSPOT doses, specifically Gallium Ga-68 radiopharmaceuticals, for clinical use at the Philadelphia VA Medical Center. The contract mandates strict adherence to current Good Manufacturing Practices (cGMP), proper labeling, and maintaining a secure chain of custody throughout the process to ensure product integrity and compliance. It is designated as a subcontract under a Total Small Business Set-Aside in accordance with FAR 19.5, targeting eligible small businesses within the pharmaceutical manufacturing sector. The contract’s solicitation was posted on May 18, 2026, with a response deadline of May 20, 2026. The place of performance is specified as Philadelphia, with the procurement overseen by the Department of Veterans Affairs through the 244-NETWORK Contract Office 4 (36C244). The NAICS code for this contract is 325412, which pertains to pharmaceutical preparation manufacturing. This contract supports the VA’s clinical needs by ensuring a reliable supply of radiopharmaceutical doses essential for diagnostic imaging, thereby enhancing patient care capabilities at the medical center.